J
Julie M. Vose
Researcher at University of Nebraska Medical Center
Publications - 569
Citations - 51589
Julie M. Vose is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Transplantation & Lymphoma. The author has an hindex of 97, co-authored 541 publications receiving 46915 citations. Previous affiliations of Julie M. Vose include Memorial Hospital of South Bend.
Papers
More filters
Journal ArticleDOI
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
Sandeep S. Dave,George E. Wright,Bruce K. Tan,Andreas Rosenwald,Andreas Rosenwald,Randy D. Gascoyne,Wing C. Chan,Richard I. Fisher,Rita M. Braziel,Lisa M. Rimsza,Thomas M. Grogan,Thomas P. Miller,Michael LeBlanc,Timothy C. Greiner,Dennis D. Weisenburger,James C. Lynch,Julie M. Vose,James O. Armitage,Erlend B. Smeland,Stein Kvaløy,Harald Holte,Jan Delabie,Joseph M. Connors,Peter M. Lansdorp,Qin Ouyang,T. Andrew Lister,Andrew Davies,Andrew J. Norton,H. Konrad Muller-Hermelink,German Ott,Elias Campo,Emilio Montserrat,Wyndham H. Wilson,Elaine S. Jaffe,Richard M. Simon,Liming Yang,John Powell,Hong Zhao,Neta Goldschmidt,Michael Chiorazzi,Louis M. Staudt +40 more
TL;DR: The length of survival among patients with follicular lymphoma correlates with the molecular features of nonmalignant immune cells present in the tumor at diagnosis.
Journal ArticleDOI
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
Andreas Rosenwald,George E. Wright,Karen Leroy,Xin-You Yu,Philippe Gaulard,Randy D. Gascoyne,Wing C. Chan,Tong Zhao,Corinne Haioun,Timothy C. Greiner,Dennis D. Weisenburger,James C. Lynch,Julie M. Vose,James O. Armitage,Erlend B. Smeland,Stein Kvaløy,Harald Holte,Jan Delabie,Elias Campo,Emili Montserrat,Armando López-Guillermo,German Ott,H. Konrad Muller-Hermelink,Joseph M. Connors,Rita M. Braziel,Thomas M. Grogan,Thomas M. Grogan,Richard I. Fisher,Richard I. Fisher,Thomas P. Miller,Thomas P. Miller,Michael LeBlanc,Michael LeBlanc,Michael Chiorazzi,Hong-Bo Zhao,Liming Yang,John Powell,Wyndham H. Wilson,Elaine S. Jaffe,Richard Simon,Richard D. Klausner,Louis M. Staudt +41 more
TL;DR: Gene expression profiling strongly supported a relationship between PMBL and Hodgkin lymphoma: over one third of the genes that were more highly expressed in PMBL than in other DLBCLs were also characteristically expressed in Hodgkinymphoma cells.
Journal ArticleDOI
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Andreas Rosenwald,George E. Wright,Adrian Wiestner,Wing C. Chan,Wing C. Chan,Joseph M. Connors,Joseph M. Connors,Elias Campo,Elias Campo,Randy D. Gascoyne,Randy D. Gascoyne,Thomas M. Grogan,Thomas M. Grogan,H. Konrad Muller-Hermelink,H. Konrad Muller-Hermelink,Erlend B. Smeland,Erlend B. Smeland,Michael Chiorazzi,Jena M. Giltnane,Elaine M. Hurt,Hong Zhao,Lauren Averett,Sarah E. Henrickson,Liming Yang,John Powell,Wyndham H. Wilson,Elaine S. Jaffe,Richard M. Simon,Richard D. Klausner,Emilio Montserrat,Emilio Montserrat,Francesc Bosch,Francesc Bosch,Timothy C. Greiner,Dennis D. Weisenburger,Dennis D. Weisenburger,Warren G. Sanger,Bhavana J. Dave,James C. Lynch,James C. Lynch,Julie M. Vose,James O. Armitage,Richard I. Fisher,Richard I. Fisher,Thomas P. Miller,Thomas P. Miller,Michael LeBlanc,Michael LeBlanc,German Ott,German Ott,Stein Kvaløy,Stein Kvaløy,Harald Holte,Harald Holte,Jan Delabie,Jan Delabie,Louis M. Staudt +56 more
TL;DR: A quantitative model of the aberrant cell cycle regulation in MCL is proposed that provides a rationale for the design of cell cycle inhibitor therapy in this malignancy.
Journal ArticleDOI
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson,Ryan M. Young,Roland Schmitz,Yandan Yang,Stefania Pittaluga,George E. Wright,Chih Jian Lih,P. Mickey Williams,Arthur L. Shaffer,John F. Gerecitano,John F. Gerecitano,Sven de Vos,Andre Goy,Vaishalee P. Kenkre,Paul M. Barr,Kristie A. Blum,Andrei R. Shustov,Ranjana H. Advani,Nathan Fowler,Julie M. Vose,Rebecca Elstrom,Thomas M. Habermann,Jacqueline C. Barrientos,Jesse McGreivy,Maria Fardis,Betty Y. Chang,Fong Clow,Brian Munneke,Davina Moussa,Darrin M. Beaupre,Louis M. Staudt +30 more
TL;DR: The selective development of ibrutinib for the treatment of ABC DLBCL is supported, with the highest number of responses occurred in ABC tumors that lacked BCR mutations, suggesting that oncogenic BCR signaling in ABC does not require B CR mutations and might be initiated by non-genetic mechanisms.
Journal ArticleDOI
Molecular diagnosis of Burkitt's lymphoma.
Sandeep S. Dave,Kai Fu,George E. Wright,Lloyd T. Lam,Philip M. Kluin,Evert Jan Boerma,Timothy C. Greiner,Dennis D. Weisenburger,Andreas Rosenwald,German Ott,Hans Konrad Müller-Hermelink,Randy D. Gascoyne,Jan Delabie,Lisa M. Rimsza,Rita M. Braziel,Thomas M. Grogan,Elias Campo,Elaine S. Jaffe,Bhavana J. Dave,Warren G. Sanger,Martin Bast,Julie M. Vose,James O. Armitage,Joseph M. Connors,Erlend B. Smeland,Stein Kvaløy,Harald Holte,Richard I. Fisher,Thomas P. Miller,Emilio Montserrat,Wyndham H. Wilson,Manisha Bahl,Hong Zhao,Liming Yang,John Powell,Richard M. Simon,Wing C. Chan,Louis M. Staudt +37 more
TL;DR: Gene-expression profiling is an accurate, quantitative method for distinguishing Burkitt's lymphoma from diffuse large-B-cell lymphoma and the overall survival was superior among those who had received intensive chemotherapy regimens instead of lower-dose regimens.